BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2641031)

  • 1. Buprenorphine treatment of cocaine abuse.
    Kosten TR; Morgan CJ; Kleber HD
    NIDA Res Monogr; 1989; 95():461. PubMed ID: 2641031
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of cocaine abuse in methadone maintenance programs.
    Kolar AF
    Md Med J; 1989 Dec; 38(12):1067-8. PubMed ID: 2615578
    [No Abstract]   [Full Text] [Related]  

  • 3. Desipramine treatment of cocaine abuse in methadone maintenance patients.
    Arndt I; Dorozynsky L; Woody G; McLellan AT; O'Brien CP
    NIDA Res Monogr; 1989; 95():322-3. PubMed ID: 2701300
    [No Abstract]   [Full Text] [Related]  

  • 4. Outpatient comparison of buprenorphine and methadone maintenance. II. Effects on cocaine usage, retention time in study and missed clinic visits.
    Fudala PJ; Johnson RE; Jaffe JH
    NIDA Res Monogr; 1990; 105():587-8. PubMed ID: 1876131
    [No Abstract]   [Full Text] [Related]  

  • 5. Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence.
    Compton PA; Ling W; Charuvastra VC; Wesson DR
    J Addict Dis; 1995; 14(3):97-114. PubMed ID: 8555282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse.
    Schottenfeld RS; Pakes JR; Oliveto A; Ziedonis D; Kosten TR
    Arch Gen Psychiatry; 1997 Aug; 54(8):713-20. PubMed ID: 9283506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cocaine abuse in maintenance therapy with methadone in narcotic dependent patients].
    Ortner R; Peternell A; Kraigher D; Schindler S; Topitz A; Fischer G
    Wien Klin Wochenschr; 2001 Dec; 113(23-24):934-8. PubMed ID: 11802509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open pilot study of bupropion and psychotherapy for the treatment of cocaine abuse in methadone-maintained patients.
    Margolin A; Kosten T; Petrakis I; Avants SK; Kosten T
    NIDA Res Monogr; 1990; 105():367-8. PubMed ID: 1908556
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance.
    Stine SM; Kosten TR
    Am J Drug Alcohol Abuse; 1994 Nov; 20(4):445-58. PubMed ID: 7832179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine abuse among methadone-maintained patients.
    Oliveto A; Kosten T; Schottenfeld R; Ziedonis D
    Am J Psychiatry; 1993 Nov; 150(11):1755. PubMed ID: 8214197
    [No Abstract]   [Full Text] [Related]  

  • 14. Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    Psychopharmacology (Berl); 1994 Dec; 116(4):401-6. PubMed ID: 7701040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological treatment of substance dependence from a neuroscientific perspective (I): opiates and cocaine].
    Haro G; Cervera G; Martínez-Raga J; Pérez-Gálvez B; Fernández-Garcés M; Sanjuan J
    Actas Esp Psiquiatr; 2003; 31(4):205-19. PubMed ID: 12838444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in Buprenorphine- versus methadone-maintained patients.
    Schottenfeld RS; Pakes JR; Kosten TR
    J Nerv Ment Dis; 1998 Jan; 186(1):35-43. PubMed ID: 9457145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine: beyond methadone?
    Rosen MI; Kosten TR
    Hosp Community Psychiatry; 1991 Apr; 42(4):347-9. PubMed ID: 2050347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of opioid antagonists in treating intravenous cocaine abuse.
    Kosten TR; Kleber HD; Morgan C
    Life Sci; 1989; 44(13):887-92. PubMed ID: 2927249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A treatment crisis: cocaine use by clients in methadone maintenance programs.
    Kolar AF; Brown BS; Weddington WW; Ball JC
    NIDA Res Monogr; 1990; 105():365-6. PubMed ID: 1876042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.